A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults

Patrick Martin, David Pierce, Mary Corcoran, Maria Velinova, Stuart Hossack, Mieke Hoppenbrouwers
  • Drug Design Development and Therapy, February 2015, Dove Medical Press
  • DOI: 10.2147/dddt.s64621
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr David Montague Pierce

In partnership with: